Literature DB >> 23679031

Anti-reflux surgery for patients with esophageal atresia.

J A Tovar1, A C Fragoso.   

Abstract

Gastroesophageal reflux (GER) is almost constant in esophageal atresia and tracheoesophageal fistula (EA/TEF). These patients resist medical treatment and require antireflux surgery quite often. The present review examines why this happens, the long-term consequences of GER and the main indications and results of fundoplication in this particular group of patients. The esophagus of EA/TEF patients is malformed and has abnormal extrinsic and intrinsic innervation and, consequently, deficient sphincter function and dysmotility. These anomalies are permanent. Fifty percent of patients overall have GER, and one-fifth have Barrett's metaplasia. Close to 100%, GER of pure and long-gap cases require fundoplication. In the long run, these patients have 50-fold higher risk of carcinoma than the control population. GER in EA/TEF does not respond well to dietary, antacid, or prokinetic medication. Surgery is necessary in protracted anastomotic stenoses, in pure and long-gap cases, and when there is an associated duodenal atresia. It should be indicated as well in other symptomatic cases when conservative treatment fails. However, confection of a suitable wrap is anatomically difficult in this condition as shown by a failure rate of 30% that is also explained by the persistence for life of the conditions facilitating GER.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Year:  2013        PMID: 23679031     DOI: 10.1111/dote.12063

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  9 in total

Review 1.  Surveillance in Patients With Esophageal Atresia/Tracheoesophageal Fistula.

Authors:  Arunjot Singh; William Middlesworth; Julie Khlevner
Journal:  Curr Gastroenterol Rep       Date:  2017-01

Review 2.  How to Care for Patients with EA-TEF: The Known and the Unknown.

Authors:  Hayat Mousa; Usha Krishnan; Maheen Hassan; Luigi Dall'Oglio; Rachel Rosen; Frédéric Gottrand; Christophe Faure
Journal:  Curr Gastroenterol Rep       Date:  2017-11-25

Review 3.  The Surgical Correction of Congenital Deformities: The Treatment of Diaphragmatic Hernia, Esophageal Atresia and Small Bowel Atresia.

Authors:  Lucas M Wessel; Jörg Fuchs; Udo Rolle
Journal:  Dtsch Arztebl Int       Date:  2015-05-15       Impact factor: 5.594

Review 4.  Feeding Difficulties in Children with Esophageal Atresia.

Authors:  Lisa Mahoney; Rachel Rosen
Journal:  Paediatr Respir Rev       Date:  2015-06-24       Impact factor: 2.726

5.  Evaluation of the intraoperative risk factors for esophageal anastomotic complications after primary repair of esophageal atresia with tracheoesophageal fistula.

Authors:  Yuichi Okata; Kosaku Maeda; Yuko Bitoh; Yasuhiko Mishima; Akihiko Tamaki; Keiichi Morita; Kosuke Endo; Chieko Hisamatsu; Hiroaki Fukuzawa; Akiko Yokoi
Journal:  Pediatr Surg Int       Date:  2016-07-26       Impact factor: 1.827

Review 6.  Gastroesophageal reflux and congenital gastrointestinal malformations.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Eloisa Gitto; Carmelo Salpietro; Antonio Centorrino; Gianfranco Scalfari; Giuseppe Santoro; Pietro Impellizzeri; Carmelo Romeo
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 7.  Fundoplication in Patients with Esophageal Atresia: Patient Selection, Indications, and Outcomes.

Authors:  Risto J Rintala
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

8.  Laparoscopic fundoplication after oesophageal atresia repair.

Authors:  Maria-Grazia Scarpa; Daniela Codrich; Miriam Duci; Damiana Olenik; Jürgen Schleef
Journal:  Afr J Paediatr Surg       Date:  2022 Jul-Sep

9.  Contractile profile of esophageal and gastric fundus strips in experimental doxorubicin-induced esophageal atresia.

Authors:  F A Capeto; F J B Lima; W Okoba; F L Ramos; T F A Messias; G A Rigonatto; L Sbragia; P J C Magalhães; A A Melo-Filho
Journal:  Braz J Med Biol Res       Date:  2015-03-06       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.